Pressure-overload cardiomyopathy in end-stage renal disease

被引:19
|
作者
London, GM [1 ]
Guérin, AP [1 ]
Marchais, SJ [1 ]
机构
[1] Ctr Hosp FH Manhes, F-91700 Fleury Merogis, France
来源
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | 1999年 / 8卷 / 02期
关键词
D O I
10.1097/00041552-199903000-00005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Left ventricular Hypertrophy is the most frequent alteration in ESRD and is an independent risk factor for survival. Left Ventricular Hypertrophy is an 'adaptive' response to increase in cardiac work that results in ESRD patients from increased stroke volume and high-output state (flow/volume overload, an increased opposition to left ventricular ejection (pressure overload), and an increased heart rate. Pressure overload is determined by peripheral resistance, arterial stiffness and elevated arterial inertance, while peripheral resistance is usually within the normal values. Increased arterial stiffness and inertance are associated with remodelling of large arteries which are dilated and hypertrophied, Arterial hypertrophy is accompanied by alterations of the intrinsic elastic properties of arterial walls that contribute to amplify the pressure load. Curr Opin Nephrol Hypertens 8:179-186. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 50 条
  • [31] Hypertension in end-stage renal disease
    Martínez-Maldonado, M
    KIDNEY INTERNATIONAL, 1998, 54 : S67 - S72
  • [32] End-Stage Renal Disease and Pregnancy
    Nadeau-Fredette, Annie-Claire
    Hladunewich, Michelle
    Hui, Dini
    Keunen, Johannes
    Chan, Christopher T.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2013, 20 (03) : 246 - 252
  • [33] Pregnancy and End-Stage Renal Disease
    Tangren, Jessica
    Nadel, Molly
    Hladunewich, Michelle A.
    BLOOD PURIFICATION, 2018, 45 (1-3) : 194 - 200
  • [34] Adiponectin and end-stage renal disease
    Markaki A.
    Psylinakis E.
    Spyridaki A.
    Hormones, 2016, 15 (3) : 345 - 354
  • [35] Pharmacotherapy of end-stage renal disease
    Schmid, Holger
    Schiffl, Helmut
    Lederer, Stephan R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 597 - 613
  • [36] Silicosis and end-stage renal disease
    Steenland, K
    Rosenman, K
    Socie, E
    Valiante, D
    SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 2002, 28 (06) : 439 - 442
  • [37] HYPERTENSION IN END-STAGE RENAL DISEASE
    PAGE, LB
    NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (18): : 1018 - &
  • [38] Epidemiology of end-stage renal disease
    Roderick, P
    CLINICAL MEDICINE, 2002, 2 (03) : 200 - 204
  • [39] End-stage renal disease in leprosy
    Lomonte, C
    Chiarulli, G
    Cazzato, F
    Giammaria, B
    Marchio, G
    Losurdo, N
    Antonelli, M
    Casucci, F
    Basile, C
    JOURNAL OF NEPHROLOGY, 2004, 17 (02) : 302 - 305
  • [40] The Relationship Between Volume Overload in End-Stage Renal Disease and Obstructive Sleep Apnea
    Roumelioti, Maria-Eleni
    Brown, Lee K.
    Unruh, Mark L.
    SEMINARS IN DIALYSIS, 2015, 28 (05) : 508 - 513